COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,626 Articles (22,913 medRxiv, 8,713 bioRxiv)

Most recent first Previous |  Page 1337: Articles 13361-13370  | Next

Mutations in SARS-CoV-2 Variants Modulate the Microscopic Dynamics of Neutralizing Antibodies
Ray, D., Quijano, R. N., Andricioaei, I.
10.1101/2021.08.13.456317 — Posted: 2021-08-16
ImputeCoVNet: 2D ResNet Autoencoder for Imputation of SARS-CoV-2 Sequences
Pesaranghader, A., Pelletier, J., Grenier, J.-C., Poujol, R., Hussin, J.
10.1101/2021.08.13.456305 — Posted: 2021-08-16
Cutting epitopes to survive: the case of lambda variant
Pascarella, S., Ciccozzi, M., Bianchi, M., Benvenuto, D., Cauda, R., Cassone, A.
10.1101/2021.08.14.456353 — Posted: 2021-08-16 Discussion: Onsite
Prediction of coronavirus 3C-like protease cleavage sites using machine-learning algorithms
Chen, H., Zhu, Z., Qiu, Y., Ge, X., Zheng, H., Peng, Y.
10.1101/2021.08.15.456422 — Posted: 2021-08-16
Antiviral face mask functionalized with solidified hand soap: low-cost infection prevention clothing against enveloped viruses such as SARS-CoV-2
Cano-Vicent, A., Tunon-Molina, A., Marti, M., Muramoto, Y., Noda, T., Takayama, K., Serrano-Aroca, A.
10.1101/2021.08.13.456326 — Posted: 2021-08-16
Peptide Scanning of SARS-CoV and SARS-CoV-2 Spike Protein Subunit 1 Reveals Potential Additional Receptor Binding Sites
Lin, W., Rafeya, J., Roschewitz, V., Smith, D., Keller, A., Zhang, Y.
10.1101/2021.08.16.456470 — Posted: 2021-08-16
A time irreversible model of nucleotide substitution for the coronavirus evolution
Misawa, K.
10.1101/2021.08.16.456444 — Posted: 2021-08-16
Infection and transmission of SARS-CoV-2 and its alpha variant in pregnant white-tailed deer
Cool, K., Gaudreault, N. N., Morozov, I., Trujillo, J. D., Meekins, D. A., McDowell, C., Carossino, M., Bold, D., Kwon, T., Balaraman, V., Madden, D. W., Libanori Artiaga, B., Pogranichniy, R. M., Roman Sosa, G., Henningson, J., Wilson, W. C., Balasuriya, U. B. R., Garcia-Sastre, A., Richt, J. A.
10.1101/2021.08.15.456341 — Posted: 2021-08-16
A screening pipeline identifies a broad-spectrum inhibitor of bacterial AB toxins with cross protection against influenza A virus H1N1 and SARS-CoV-2
Wu, Y., Mahtal, N., Swistak, L., Sagadiev, S., Acharya, M., Demeret, C., Van der Werf, S., Guivel-Benhassine, F., Schwartz, O., Petracchini, S., Mettouchi, A., Paillares, E., Caramelle, L., Couvineau, P., Thai, R., Barbe, P., Keck, M., Brodin, P., Machelart, A., Sencio, V., Trottein, F., Sachse, M., Chicanne, G., Payrastre, B., Ville, F., Kreis, V., Popoff, M.-R., Johannes, L., Cintrat, J.-C., Barbier, J., Gillet, D., Lemichez, E.
10.1101/2021.08.13.454991 — Posted: 2021-08-16
Age-related susceptibility of ferrets to SARS-CoV-2 infection
Martins, M., Fernandes, M. H. V., Joshi, L. R., Diel, D.
10.1101/2021.08.16.456510 — Posted: 2021-08-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).